The utility of implantable loop recorder in the clinical management of pediatric patient with non-high-risk Brugada syndrome
Text Complet
Compartir
BACKGROUND: Brugada syndrome (BrS) is an inherited arrhythmogenic
disorder characterized by a typical ECG pattern. The syndrome has incomplete
penetrance and variable expressivity, ranging from asymptomatic to lethal
ventricular arrhythmias and sudden death at a young age in individuals with
structurally normal hearts. So, all this requires an early diagnosis and an accurate
risk stratification of this population.
HYPOTHESIS AND OBJECTIVE: We suggest the use of remote monitoring
system using a subcutaneous loop recorder as a tool to detect arrhythmic events
that can help in the risk stratification of pediatric patients with non-high-risk BrS.
METHODS AND MATERIALS: A retrospective cohort study was performed to
describe data collected by implantable loop recorder (ILR) of 34 anonymized
pediatric patients with non-high-risk BrS. Their demographic and clinical
characteristics and the results obtained in all diagnostic tests performed, were
analyzed in comparison to the detection of arrhythmic events by ILR.
RESULTS: Within 34 patients, 24 were male (70,59%) and 10 were female
(29,41%). Among total arrhythmic events detected, 5 patients (45,45%) were
previously symptomatic and 6 (54,55%) were previously asymptomatic. During a
mean follow-up of 18 months, a total of 7 cases (63,64%), ILR was triggered by
symptoms, which in the majority of them (71,43%) were proved normal sinus
rhythm/sinus tachycardia or minimal rhythm disturbances. In the two remaining
symptomatic cases (28,57%), the ECG tracing identified episodes of NSVT. That
involved a change in those patients’ therapeutic management, requiring an early
implantation of ICD. In four asymptomatic patients (36,36%) the ILR recording
was auto-activated, showing in one of those cases (25%), various episodes of
asymptomatic NSVT. In six cases (17,65%), ILR recorded episodes of abrupt
change repolarization compatible with dynamic BrS.
CONCLUSIONS: The ILR was determinant to exclude ventricular arrhythmias as
a mechanism of symptoms in 71,43% of patients, delaying ICD implantation. In
contrast, it allowed to detect ventricular arrhythmias in two symptomatic patients,
leading to an early implantation of ICD. So, the ILR allows a long-term continue
monitoring of heart rhythm in patients with increased risk of suffering life-
threatening arrhythmias and should be considered as a tool for clinical
management of paediatric patients with non-high-risk BrS